Harrow Health Inc (HROW) support and resistance · rev $114.9M
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
This page maps Harrow Health Inc (HROW) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
HROW currently screens at market cap $1.28B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new HROW 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the HROW quote page for the session range and the stock page for the full model.
Not investment advice.